Abstract
Mitotic catastrophe of cancer cells induced by drugs is characterized by low dosage and low toxicity, representing a significant advantage in the cancer treatment. Effective therapeutic options are limited for T-cell malignancies patients who are still treated by high-dose multiagent chemotherapy, potentially followed by hematopoietic stem cell transplantation, highlighting the urgency for identification of more effective anti-T-cell malignancies drugs. The use of antineoplastic drugs which induced tumor cell mitotic catastrophe would be a new strategy for cancer therapy. Nevertheless, there is still no effective mitotic catastrophe agent in T-cell malignancies. Our study showed that nonlethal dosage (ND) of GL-V9 (5-hydroxy-8-methoxy-2-phenyl-7-(4-(pyrrolidin-1-yl) butoxy) 4 H-chromen-4-one) (2 µM), a potential anticancer drug, not only attenuated cell growth and survival, but also arrested the cell cycle in G2/M phase and induced multipolar spindles, nuclear alterations (micronucleation and multinucleation), which are the most prominent morphological characteristics of mitotic catastrophe, in T-cell malignancies cell lines including Jurkat, HuT-102, and HuT-78. Moreover, ND GL-V9 could trigger DNA damage, and significantly influence several mitosis-associated proteins. Besides, results showed that ND GL-V9 increased the activity of senescence-associated β-galactosidase (SA-β-Gal) following the induction of mitotic catastrophe in Jurkat and HuT-102 cells with intact p53, while causing apoptosis in p53-deficient HuT-78 cells. We concluded that the anti-T-cell malignancies effects of ND GL-V9 and clarified the precise regulation in the process of mitosis under the action of GL-V9 in T-cell malignancies. Our data provided new evidence for the study of T-cell malignancies treatment associated with mitotic catastrophe and cellular senescence induction.
Similar content being viewed by others
Abbreviations
- T-ALL:
-
T-cell acute lymphoblastic leukemia
- T-NHL:
-
T cell non-Hodgkin lymphomas
- ND GL-V9:
-
Nonlethal dosage of GL-V9
- CHK1:
-
Checkpoint kinase 1
- CHK2:
-
Checkpoint kinase 2
- CDK1:
-
Cyclin B1-dependent kinase
- Mad2:
-
Mitotic arrest deficient 2
- Plks:
-
Polo-like kinases
- SA-β-Gal:
-
Senescence-associated β-galactosidase
- PARP:
-
Poly (ADP-ribose) polymerase
- CFSE:
-
Carboxyfluorescein diacetate succinimidyl ester
- MRD:
-
Minimal residual disease
References
Aasland D, Gotzinger L, Hauck L et al (2019) Temozolomide induces senescence and repression of DNA repair pathways in glioblastoma cells via activation of ATR-CHK1, p21, and NF-kappaB. Cancer Res 79(1):99–113. https://doi.org/10.1158/0008-5472.CAN-18-1733
Aifantis I, Raetz E, Buonamici S (2008) Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 8(5):380–390. https://doi.org/10.1038/nri2304
Andreassen PR, Lacroix FB, Lohez OD, Margolis RL (2001) Neither p21WAF1 nor 14-3-3sigma prevents G2 progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21WAF1 induces stable G1 arrest in resulting tetraploid cells. Cancer Res 61(20):7660–7668
Brown JM, Attardi LD (2005) The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 5(3):231–237. https://doi.org/10.1038/nrc1560
Bunz F, Dutriaux A, Lengauer C et al (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282(5393):1497–1501
Campisi J (2013) Aging, cellular senescence, and cancer. Annu Rev Physiol 75:685–705. https://doi.org/10.1146/annurev-physiol-030212-183653
Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G (2004) Cell death by mitotic catastrophe: a molecular definition. Oncogene 23(16):2825–2837. https://doi.org/10.1038/sj.onc.1207528
Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B (1999) 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401(6753):616–620. https://doi.org/10.1038/44188
Chen Z, Xiao Z, Chen J et al (2003) Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpoint. Mol Cancer Ther 2(6):543–548
Chen CJ, Hsu MH, Kuo SC, Lai YY, Chung JG, Huang LJ (2007) (2E)-N, N-dibutyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide induces apoptosis and cell cycle arrest in HL-60 cells. Anticancer Res 27(1A):343–349
Cimprich KA, Cortez D (2008) ATR: an essential regulator of genome integrity. Nat Rev Mol Cell Biol 9(8):616–627. https://doi.org/10.1038/nrm2450
Cogswell JP, Brown CE, Bisi JE, Neill SD (2000) Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function. Cell Growth Differ 11(12):615–623
Dietlein F, Thelen L, Jokic M et al (2014) A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDC. Cancer Discov 4(5):592–605. https://doi.org/10.1158/2159-8290.CD-13-0907
Ditchfield C, Johnson VL, Tighe A et al (2003) Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J Cell Biol 161(2):267–280. https://doi.org/10.1083/jcb.200208091
Dixon H, Norbury CJ (2002) Therapeutic exploitation of checkpoint defects in cancer cells lacking p53 function. Cell Cycle 1(6):362–368. https://doi.org/10.4161/cc.1.6.257
Eckerdt F, Yuan J, Strebhardt K (2005) Polo-like kinases and oncogenesis. Oncogene 24(2):267–276. https://doi.org/10.1038/sj.onc.1208273
Eom YW, Kim MA, Park SS et al (2005) Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype. Oncogene 24(30):4765–4777. https://doi.org/10.1038/sj.onc.1208627
Gire V, Dulic V (2015) Senescence from G2 arrest, revisited. Cell Cycle 14(3):297–304. https://doi.org/10.1080/15384101.2014.1000134
Hendzel MJ, Wei Y, Mancini MA et al (1997) Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106(6):348–360
Ianzini F, Mackey MA (1997) Spontaneous premature chromosome condensation and mitotic catastrophe following irradiation of HeLa S3 cells. Int J Radiat Biol 72(4):409–421
Ingenhag D, Reister S, Auer F et al (2019) The homeobox transcription factor HB9 induces senescence and blocks differentiation in hematopoietic stem and progenitor cells. Haematologica 104(1):35–46. https://doi.org/10.3324/haematol.2018.189407
Jackson SP, Bartek J (2009) The DNA-damage response in human biology and disease. Nature 461(7267):1071–1078. https://doi.org/10.1038/nature08467
Jackson JR, Patrick DR, Dar MM, Huang PS (2007) Targeted anti-mitotic therapies: can we improve on tubulin agents? Nat Rev Cancer 7(2):107–117. https://doi.org/10.1038/nrc2049
Johmura Y, Shimada M, Misaki T et al (2014) Necessary and sufficient role for a mitosis skip in senescence induction. Mol Cell 55(1):73–84. https://doi.org/10.1016/j.molcel.2014.05.003
Kelly KR, Ecsedy J, Mahalingam D et al (2011) Targeting aurora kinases in cancer treatment. Curr Drug Targets 12(14):2067–2078
Khongkow P, Gomes AR, Gong C et al (2016) Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance. Oncogene 35(8):990–1002. https://doi.org/10.1038/onc.2015.152
Krenning L, Feringa FM, Shaltiel IA, van den Berg J, Medema RH (2014) Transient activation of p53 in G2 phase is sufficient to induce senescence. Mol Cell 55(1):59–72. https://doi.org/10.1016/j.molcel.2014.05.007
Kroemer G, Galluzzi L, Vandenabeele P et al (2009) Classification of cell death: recommendations of the nomenclature committee on cell death 2009. Cell Death Differ 16(1):3–11. https://doi.org/10.1038/cdd.2008.150
Lens SM, Voest EE, Medema RH (2010) Shared and separate functions of polo-like kinases and aurora kinases in cancer. Nat Rev Cancer 10(12):825–841. https://doi.org/10.1038/nrc2964
Li L, Chen P, Ling Y et al (2011) Inhibitory effects of GL-V9 on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-2/9. Eur J Pharm Sci 43(5):393–399. https://doi.org/10.1016/j.ejps.2011.06.001
Li H, Xu J, Zhou Y et al (2017) PLSCR1/IP3R1/Ca(2+) axis contributes to differentiation of primary AML cells induced by wogonoside. Cell Death Dis 8(5):e2768. https://doi.org/10.1038/cddis.2017.175
Li H, Lu N, Yu X et al (2018) Oroxylin A, a natural compound, mitigates the negative effects of TNFalpha-treated acute myelogenous leukemia cells. Carcinogenesis 39(10):1292–1303. https://doi.org/10.1093/carcin/bgy004
Lopez-Contreras AJ, Fernandez-Capetillo O (2010) The ATR barrier to replication-born DNA damage. DNA Repair (Amst) 9(12):1249–1255. https://doi.org/10.1016/j.dnarep.2010.09.012
Mansilla S, Bataller M, Portugal J (2006) Mitotic catastrophe as a consequence of chemotherapy. Anticancer Agents Med Chem 6(6):589–602
Mc Gee MM (2015) Targeting the mitotic catastrophe signaling pathway in cancer. Mediat Inflamm 2015:146282. https://doi.org/10.1155/2015/146282
Muller A, Gillissen B, Richter A et al (2018) Pan-class I PI3-kinase inhibitor BKM120 induces MEK1/2-dependent mitotic catastrophe in non-hodgkin lymphoma leading to apoptosis or polyploidy determined by Bax/Bak and p53. Cell Death Dis 9(3):384. https://doi.org/10.1038/s41419-018-0413-4
Nitta M, Kobayashi O, Honda S et al (2004) Spindle checkpoint function is required for mitotic catastrophe induced by DNA-damaging agents. Oncogene 23(39):6548–6558. https://doi.org/10.1038/sj.onc.1207873
Portugal J, Mansilla S, Bataller M (2010) Mechanisms of drug-induced mitotic catastrophe in cancer cells. Curr Pharm Des 16(1):69–78
Roninson IB, Broude EV, Chang BD (2001) If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updates 4(5):303–313. https://doi.org/10.1054/drup.2001.0213
Ross JA, Spadaro M, Rosado DC, Cavallo F, Kirken RA, Pericle F (2014) Inhibition of JAK3 with a novel, selective and orally active small molecule induces therapeutic response in T-cell malignancies. Leukemia 28(4):941–944. https://doi.org/10.1038/leu.2013.309
Sato N, Mizumoto K, Nakamura M, Tanaka M (2000) Radiation-induced centrosome overduplication and multiple mitotic spindles in human tumor cells. Exp Cell Res 255(2):321–326. https://doi.org/10.1006/excr.1999.4797
Schmit TL, Ahmad N (2007) Regulation of mitosis via mitotic kinases: new opportunities for cancer management. Mol Cancer Ther 6(7):1920–1931. https://doi.org/10.1158/1535-7163.MCT-06-0781
Schrappe M, Hunger SP, Pui CH et al (2012) Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med 366(15):1371–1381. https://doi.org/10.1056/NEJMoa1110169
Smith J, Tho LM, Xu N, Gillespie DA (2010) The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res 108:73–112. https://doi.org/10.1016/B978-0-12-380888-2.00003-0
Sorensen CS, Syljuasen RG (2012) Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication. Nucleic Acids Res 40(2):477–486. https://doi.org/10.1093/nar/gkr697
Sudakin V, Yen TJ (2007) Targeting mitosis for anti-cancer therapy. BioDrugs 21(4):225–233. https://doi.org/10.2165/00063030-200721040-00003
te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP (2002) DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res 62(6):1876–1883
Vakifahmetoglu H, Olsson M, Zhivotovsky B (2008) Death through a tragedy: mitotic catastrophe. Cell Death Differ 15(7):1153–1162. https://doi.org/10.1038/cdd.2008.47
Vitale I, Galluzzi L, Castedo M, Kroemer G (2011) Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol 12(6):385–392. https://doi.org/10.1038/nrm3115
Weaver BA, Cleveland DW (2005) Decoding the links between mitosis, cancer, and chemotherapy: The mitotic checkpoint, adaptation, and cell death. Cancer Cell 8(1):7–12. https://doi.org/10.1016/j.ccr.2005.06.011
Yang L, He Z, Yao J et al (2018) Regulation of AMPK-related glycolipid metabolism imbalances redox homeostasis and inhibits anchorage independent growth in human breast cancer cells. Redox Biol 17:180–191. https://doi.org/10.1016/j.redox.2018.04.016
Ye C, Zhang X, Wan J et al (2013) Radiation-induced cellular senescence results from a slippage of long-term G2 arrested cells into G1 phase. Cell Cycle 12(9):1424–1432. https://doi.org/10.4161/cc.24528
Yun M, Han YH, Yoon SH et al (2009) p31comet induces cellular senescence through p21 accumulation and Mad2 disruption. Mol Cancer Res 7(3):371–382. https://doi.org/10.1158/1541-7786.MCR-08-0056
Zhang X, Kang Y, Huo T et al (2017) GL-V9 induced upregulation and mitochondrial localization of NAG-1 associates with ROS generation and cell death in hepatocellular carcinoma cells. Free Radic Biol Med 112:49–59. https://doi.org/10.1016/j.freeradbiomed.2017.07.011
Zhao K, Li G, Yao Y et al (2017a) Activation of phospholipase C-gamma1 and translocation of phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase contribute to GL-V9-induced apoptosis in human gastric cancer cells. Exp Cell Res 356(1):8–19. https://doi.org/10.1016/j.yexcr.2017.03.063
Zhao Y, Guo Q, Zhao K et al (2017b) Small molecule GL-V9 protects against colitis-associated colorectal cancer by limiting NLRP3 inflammasome through autophagy. Oncoimmunology 7(1):e1375640. https://doi.org/10.1080/2162402X.2017.1375640
Acknowledgements
This work was supported by the Drug Innovation Major Project (Nos. 2017ZX09301014, 2018ZX09711001-003-007, 2017ZX09101003-005-023), the National Science and Technology Major Project (No. 2018ZX09711001-005-023), the Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University (No. SKLNMZZCX201823), the Nation Natural Science Foundation of China (Nos. 81903647, 81503096, 81673461, 81873046, 81830105), Project funded by China Postdoctoral Science Foundation (No. 2018M642373), Natural Science Foundation of Jiangsu province (Nos. BK20190560 and BE2018711), Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT-IRT1193), Nanjing Medical Science and Technology Development Project (YKK17074), the Open Project of State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine (Nos. TCMQ and E201704), and “Double First-Class” University project (CPU 2018GF11, CPU2018GF05).
Author information
Authors and Affiliations
Contributions
HL designed and performed research and analyzed data and wrote the manuscript; PH and ZW performed research. HW and XY analyzed data; YQ collected data; XW and MZ performed statistical analysis; JX edited the manuscript; ZL analyzed the compound; QG and HH conceptualized the project, directed experiment design and data analysis.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, H., Hu, P., Wang, Z. et al. Mitotic catastrophe and p53-dependent senescence induction in T-cell malignancies exposed to nonlethal dosage of GL-V9. Arch Toxicol 94, 305–323 (2020). https://doi.org/10.1007/s00204-019-02623-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-019-02623-2